MDS and secondary AML display unique patterns and abundance of aberrant DNA methylation

Overview of attention for article published in Blood, August 2009

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (80th percentile)
Above-average Attention Score compared to outputs of the same age and source (57th percentile)

Mentioned by

patent: 6 patents

f1000: 1 research highlight platform

Readers on

mendeley: 214 Mendeley
citeulike: 1 CiteULike

So far, Altmetric has seen 6 patents that reference this research output.

Dactinomycin compositions and methods for the treatment of myelodysplastic syndrome and…

Grant US-11975111-B2

United States of America

07 May 2024

Biomarkers for predicting responsiveness to decitabine therapy

Grant US-11793825-B2

United States of America

24 Oct 2023

Dactinomycin compositions and methods for the treatment of myelodysplastic syndrome and…

Grant US-10973773-B2

United States of America

13 Apr 2021

Biomarkers for predicting responsiveness to decitabine therapy

Grant US-10940160-B2

United States of America

09 Mar 2021

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 2 additional patents.